SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment
- DOI
- 10.3389/frtra.2026.1927374
- Published
- 2026-08-18
- Container
- Frontiers in Transplantation
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/frtra.2026.1927374,
title = {SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment},
author = {Lino Henkel and Lisa Ingmanns and Florian Westphal and Amélie F. Menke and Hermann Pavenstädt and Ulrich Jehn and Göran R. Boeckel and Stefan Reuter},
year = {2026},
journal = {Frontiers in Transplantation},
doi = {10.3389/frtra.2026.1927374},
url = {https://doi.org/10.3389/frtra.2026.1927374}
}RIS
TY - JOUR TI - SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment AU - Lino Henkel AU - Lisa Ingmanns AU - Florian Westphal AU - Amélie F. Menke AU - Hermann Pavenstädt AU - Ulrich Jehn AU - Göran R. Boeckel AU - Stefan Reuter PY - 2026 JO - Frontiers in Transplantation DO - 10.3389/frtra.2026.1927374 UR - https://doi.org/10.3389/frtra.2026.1927374 ER -
APA
Henkel, L., Ingmanns, L., Westphal, F., Menke, A. F., Pavenstädt, H., Jehn, U., Boeckel, G. R., & Reuter, S. (2026). SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment. Frontiers in Transplantation. https://doi.org/10.3389/frtra.2026.1927374
Source records
- crossref · retrieved 2026-09-26T09:15:52.083Z